M&A Deal Summary

Knight Acquires Grupo Biotoscana

On November 29, 2019, Knight acquired life science company Grupo Biotoscana

Acquisition Highlights
  • This is Knight’s 1st transaction in the Life Science sector.
  • This is Knight’s 1st transaction in Uruguay.

M&A Deal Summary
Date 2019-11-29
Target Grupo Biotoscana
Sector Life Science
Buyer(s) Knight
Deal Type Add-on Acquisition

Target

Grupo Biotoscana

Montevideo, Uruguay
Biotoscana Investments SA is a biopharmaceutical group that operates in the fast-growing Latin American region and focuses on rapidly growing market segments such as infectious diseases, oncology and onco-hematology, special treatments, immunology and inflammation, and orphan/rare diseases, among others. Biotoscana Investments was founded in 2011 and is based in Montevideo, Uruguay.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Knight

Montreal, Quebec, Canada
Category Company
Founded 2013
Sector Life Science
Employees725
Revenue 328M CAD (2023)
DESCRIPTION

Knight is a biopharmaceutical group that operates in the fast-growing Latin American region and focuses on rapidly growing market segments such as infectious diseases, oncology and onco-hematology, special treatments, immunology and inflammation, and orphan/rare diseases, among others. Knight was founded in 2013 and is based in Montreal, Canada.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (Uruguay) 1 of 1
Year (2019) 1 of 1
Mergr

Product

Company

Legal